BANK OF MONTREAL /CAN/ - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 58 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2017$1,0003800.0%0.00%
Q3 2017$03800.0%0.00%
Q2 2017$03800.0%0.00%
Q1 2017$0
-100.0%
380
-23.5%
0.00%
Q4 2016$1,000
-88.9%
497
-79.4%
0.00%
Q3 2016$9,000
-92.4%
2,417
-92.7%
0.00%
Q2 2016$118,000
+11700.0%
33,037
+13665.4%
0.00%
Q4 2015$1,000
-98.4%
240
-95.2%
0.00%
Q1 2015$64,0005,0000.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2017
NameSharesValueWeighting ↓
CARL DOMINO INC 58,435$190,0000.18%
VAN DEN BERG MANAGEMENT I, INC 165,900$584,0000.07%
Granite Investment Partners, LLC 141,206$497,0000.04%
ORACLE INVESTMENT MANAGEMENT INC 50,804$179,0000.03%
JW Asset Management, LLC 8,500$30,0000.02%
Psagot Value Holdings Ltd. 55,362$195,0000.01%
Financial Architects, Inc 5,056$18,0000.01%
B. Riley Wealth Advisors, Inc. 48,226$19,0000.00%
Virtu KCG Holdings LLC 43,205$152,0000.00%
Edge Wealth Management LLC 2,000$7,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders